Technical Standards and Guidelines for Huntington Disease Testing

Genetics in Medicine

Volumn 6, Issue 1, 2004, Pages 61-65

  Potter, Nicholas T ^b   Spector, Elaine B ^a,b   Prior, Thomas W ^a,b  

^a Mol Subcom Lab Qual Assur Comm   (United States)

^b Huntington Dis Molec Working Group   (United States)

Author keywords

Genetic testing; HD; Huntington disease; Medical genetics; Molecular diagnostics

Indexed keywords

CLINICAL LABORATORY; CYTOGENETICS; HUNTINGTON CHOREA; MOLECULAR GENETICS; PRACTICE GUIDELINE; QUALITY CONTROL; REVIEW; TECHNIQUE; TECHNOLOGY;

CREDENTIALING; GENETIC SCREENING; GUIDELINES; HUMANS; HUNTINGTON DISEASE; LABORATORIES; QUALITY ASSURANCE, HEALTH CARE;

EID: 0842327450     PISSN: 10983600     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.GIM.0000106165.74751.15     Document Type: Review

References (35)

1. Nance MA, Seltzer W, Ashizawa T, Bennett R, McIntosh N, Myers RH et al. ACMG/ASHG Statement. Laboratory guidelines for Huntington disease genetic testing. Am J Hum Genet 1998;62:1243-1247.
2. Kremer B, Goldberg P, Andrew SE, Theilmann J, Telenius H, Zeisler J et al. A worldwide study of the Huntington's disease mutation. The sensitivity and specificity of measuring CAG repeats. N Engl J Med 1994;330:1401-1406.
3. McGlennen RC, Allinson PS, Matthias-Hagen VL, Parker TL, Lovell MA, Kelley TE. Evidence of an unstable paternal 27 CAG repeat allele in the huntingtin gene giving rise to clinically overt Huntington disease in a patient with the genotype (17/38). Am J Hum Genet 1995;57:A246.
4. Myers RH, MacDonald ME, Koroshetz WJ, Duyao MP, Ambrose CM, Taylor SAM et al. De novo expansion of a (CAG)n repeat in sporadic Huntington's disease. Nature Genet 1993;5:168-173.
5. Goldberg YP, Kremer B, Andrew SE, Theilman J, Graham RK, Squitieri F et al. Molecular analysis of new mutations for Huntington's disease: intermediate alleles and sex of origin effects. Nature Genet 1993;5:174-179.
6. Goldberg YP, McMurray CT, Zeisler J, Almqvist E, Sillence D, Richards F et al. Increased instability of intermediate alleles in families with sporadic Huntington disease compared to similar sized intermediate alleles in the general population. Hum Molec Genet 1995;4:1911-1918.
7. Chong SS, Almqvist E, Telenius H, LaTray L, Nichol K, Bourdelat-Parks B et al. Contribution of DNA sequence and CAG size to mutation frequencies of intermediate alleles for Huntington disease: evidence from single sperm analysis. Hum Molec Genet 1997;6:301-309.
8. Rubinsztein DC, Leggo J, Coles R, Almqvist E, Biancalana V, Cassiman J-J et al. Phenotypic characterization of individuals with 30-40 CAG repeats in the Huntington disease (HD) gene reveals HD cases with 36 repeats and apparently normal elderly individuals with 36-39 repeats. Am J Hum Genet 1996;59:16-22.
9. Brinkman RR, Mezei MM, Theilman J, Almqvist E, Hayden MR. The likelihood of being affected with Huntington disease by a particular age, for a specific CAG size. Am J Hum Genet 1997;60:1202-1210.
10. Nance MA, Mathias-Hagen V, Breningstall G, Wick MJ, McGlennen RC. Analysis of a very large trinucleotide repeat in a patient with juvenile Huntington's disease. Neurology 1999;52:392-394.
11. Telenius H, Kremer B, Goldberg YP, Theilman J, Andrew SE, Zeisler J et al. Somatic and gonadal mosaicism of the Huntington disease gene CAG repeat in brain and sperm. Nature Genet 1994;6:409-413.
12. American College of Medical Genetics. Standards and guidelines for clinical genetics laboratories, 3rd edition. American College of Medical Genetics, 2002.
13. The Huntington's disease collaborative research group. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell 1993;72:971-983.
14. Reiss O, Norremoelle A, Soerensen SA, Epplen JT. Improved PCR conditions for the stretch of (CAG)n repeats causing Huntington's disease. Hum Mol Genet 1993;2: 637.
15. Valdes JM, Tagle DA, Elmer IW, Collins FS. A simple non-radioactive method for the diagnosis of Huntington's disease. Hum Mol Genet 1993;2:633-634.
16. Warner JP, Barron L, Brock DJP. A new polymerase chain reaction (PCR) assay for the trinucleotide repeat that is unstable and expanded in Huntington's disease. Mol Cell Probes 1993;7:235-239.
17. Andrew SE, Goldberg YP, Theilman J, Zeisler J, Hayden MR. A CCG repeat polymorphism adjacent to the CAG repeat in the Huntington disease gene: Implications for diagnostic accuracy and predictive testing. Hum Mol Genet 1994;3:65-67.
18. Le H, Fung D, Trent RJ. Applications of capillary electrophoresis in DNA mutation analysis of genetic disorders. Mol Pathol 1997;50:261-265.
19. Williams LC, Hegde MR, Herrera G, Stapleton PM, Love DR. Comparative semi-automated analysis of (CAG) repeats in the Huntington disease gene: Use of internal standards. Mol Cell Probes 1999;13:283-289.
20. Bruland O, Almqvist EW, Goldberg YP, Bowman H, Hayden MR. Accurate determination of the number of CAG repeats in the Huntington disease gene using a sequence-specific internal DNA standard. Clin Genet 1999;55:198-202.
21. Gambardella A, Muglia M, Labate A, Magariello A, Gabriele AL, Mazzei R et al. Juvenile Huntington's disease presenting as progressive myoclonic epilepsy. Neurology 2001;57:708-711.
22. Cross G, Pitt T, Sharif A, Bates G, Lehrach H. False-negative result for Huntington's disease. The Lancet 1994;343:1232.
23. Gellera C, Meoni C, Castellotti B, Zappacosta B, Girotti F, Taroni F et al. Errors in Huntington disease diagnostic test caused by trinucleotide deletion in the IT15 gene. Am J Hum Genet 1996;59:475-477.
24. Margolis RL, Stine CO, Callahan C, Rosenblatt A, Abbott MH, Sherr M et al. Two novel single-base-pair substitutions adjacent to the CAG repeat in the Huntington disease gene (IT15): implications for diagnostic testing. Am J Hum Genet 1999;64: 323-326.
25. Williams LC, Hegde MR, Nagappan R, Faull RLM, Giles J, Winship I et al. Null alleles at the Huntington disease locus: implications for diagnostics and CAG repeat instability. Genet Test 2000;4:55-60.
26. Yu S, Fimmel A, Fung D, Trent RJ. Polymorphisms in the CAG repeat: A source of error in Huntington disease DNA testing. Clin Genet 2000;58:469-472.
27. Guida M, Fenwick RG, Papp AC, Snyder PJ, Sedra M, Prior TW. Southern transfer protocol for confirmation of Huntington disease. Clin Chem 1996;42:1711-1712.
28. Andrew SE, Goldberg YP, Kremer B, Squitieri F, Theilman J, Zeisler J et al. Huntington disease without CAG expansion: Phenocopies or errors in assignment? Am J Hum Genet 1994;54:852-863.
29. Rosenblatt A, Ranen NG, Rubinsztein DC, Stine OC, Margolis RL, Wagster MV et al. Patients with features similar to Huntington's disease, without CAG expansion in huntingtin. Neurology 1998;51:215-220.
30. Moore RC, Xiang F, Monaghan J, Han D, Zhang Z, Edstrom L et al. Huntington disease phenocopy is a familial prion disease. Am J Hum Genet 2001;69:1385-1388.
31. Margolis RL, O'Hearn E, Rosenblatt A, Willour V, Holmes SE, Franz ML et al. A disorder similar to Huntington's disease is associated with a novel CAG repeat expansion. Ann Neurol 2001;50:373-380.
32. Holmes SE, O'Hearn E, Rosenblatt A, Canahan C, Hwanf HS, Ingersoll-Ashworth RG et al. A repeat expansion in the gene encoding junctophilin-3 is associated with Huntington disease-like 2. Nature Genet 2001;29:377-378.
33. Potter NT, Meyer MA, Zimmerman AW, Eisenstadt ML, Anderson IJ. Molecular and clinical findings in a family with dentatorubral-pallidoluysian atrophy. Ann Neurol 1995;37:273-277.
34. Maat-Kievit A, Helderman-van-den Enden P, Losekoot M, de Knijff P, Belfroid R, Vegter-van der Vlis M et al. Using a roster and haplotyping is useful in risk assessment for persons with intermediate and reduced penetrance alleles in Huntington disease. Am J Med Genet 2001;105:737-744.
35. Maat-Kievit A, Losekoot M, van den Boer-van den Berg H, van Ommen G-J, Niermeijier M, Breuning M et al. New problems in testing for Huntington's disease: the issue of intermediate alleles and reduced penetrance. J Med Genet 2001;38:12e-12.